Exagen Inc.XGNNASDAQ
LOADING
|||
XGN Revenue Growth (YoY Quarterly)•+37.87%
SAPRO
Growth Metrics
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -6.78% | -0.80% | +7.51% | +14.19% | +37.87% |
| Gross Profit Growth | -9.41% | +4.08% | +6.11% | +14.79% | +44.32% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +3.18% | +2.06% | +3.42% | +15.99% | +25.23% |
| Weighted Average Shares Diluted Growth | +3.18% | +2.06% | +3.42% | +15.99% | +25.67% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -95.65% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | -97.37% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -44.92% | +19.60% | +35.11% | +31.62% | +18.16% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -28.43% | -21.52% | -20.69% | +19.17% | +44.07% |
| Book Value per Share Growth | -54.66% | -58.81% | -69.03% | +3.12% | +12.55% |
| Debt Growth | -4.86% | -0.97% | -0.17% | +5.56% | +19.59% |
| R&D Expense Growth | +5.79% | +53.90% | +21.25% | +25.78% | +16.81% |
| SG&A Expenses Growth | -10.65% | -16.47% | +6.28% | +10.30% | +12.61% |
1 / 4